Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catrin E Moore

Showing results (101-110 of 109) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 109 results.
Vaccine|March 19, 2024
Vaccine value profile for Klebsiella pneumoniaeZiyaad Dangor, Nicole Benson, James A Berkley, et al.
Expert Review of Anti-Infective Therapy|September 23, 2023
Current rates of purchasing of antibiotics without a prescription across sub-Saharan Africa; rationale and potential programmes to reduce inappropriate dispensing and resistanceTiyani Milta Sono, Eugene Yeika, Aislinn Cook, et al.
Antimicrobial Agents and Chemotherapy|June 14, 2015
Erratum for Parry et al., Clinically and microbiologically derived azithromycin susceptibility breakpoints for Salmonella enterica serovars Typhi and Paratyphi AChristopher M Parry, Nga Tran Vu Thieu, Christiane Dolecek, et al.
Nature Genetics|February 27, 2007
A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosisChiea C Khor, Stephen J Chapman, Fredrik O Vannberg, et al.
Science (New York, N.Y.)|March 10, 2021
SARS-CoV-2 within-host diversity and transmissionKatrina A Lythgoe, Matthew Hall, Luca Ferretti, et al.
Antimicrobial Agents and Chemotherapy|March 4, 2015
Clinically and microbiologically derived azithromycin susceptibility breakpoints for Salmonella enterica serovars Typhi and Paratyphi AChristopher M Parry, Nga Tran Vu Thieu, Christiane Dolecek, et al.
Jac-Antimicrobial Resistance|March 28, 2025
The impact of the COVID-19 pandemic on antimicrobial usage: an international patient-level cohort studyRefath Farzana, Stephan Jürgen Harbarth, Ly-Mee Yu, et al.
Expert Review of Anti-Infective Therapy|March 20, 2025
Current access, availability and use of antibiotics in primary care among key low- and middle-income countries and the policy implicationsZikria Saleem, Biset Asrade Mekonnen, Ebiowei Samuel Orubu, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 24, 2004
Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistanceMatthew T G Holden, Edward J Feil, Jodi A Lindsay, et al.
Pageof 11

Showing results (101-110 of 109) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 109 results.
Vaccine|March 19, 2024
Vaccine value profile for Klebsiella pneumoniaeZiyaad Dangor, Nicole Benson, James A Berkley, et al.
Expert Review of Anti-Infective Therapy|September 23, 2023
Current rates of purchasing of antibiotics without a prescription across sub-Saharan Africa; rationale and potential programmes to reduce inappropriate dispensing and resistanceTiyani Milta Sono, Eugene Yeika, Aislinn Cook, et al.
Antimicrobial Agents and Chemotherapy|June 14, 2015
Erratum for Parry et al., Clinically and microbiologically derived azithromycin susceptibility breakpoints for Salmonella enterica serovars Typhi and Paratyphi AChristopher M Parry, Nga Tran Vu Thieu, Christiane Dolecek, et al.
Nature Genetics|February 27, 2007
A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosisChiea C Khor, Stephen J Chapman, Fredrik O Vannberg, et al.
Science (New York, N.Y.)|March 10, 2021
SARS-CoV-2 within-host diversity and transmissionKatrina A Lythgoe, Matthew Hall, Luca Ferretti, et al.
Antimicrobial Agents and Chemotherapy|March 4, 2015
Clinically and microbiologically derived azithromycin susceptibility breakpoints for Salmonella enterica serovars Typhi and Paratyphi AChristopher M Parry, Nga Tran Vu Thieu, Christiane Dolecek, et al.
Jac-Antimicrobial Resistance|March 28, 2025
The impact of the COVID-19 pandemic on antimicrobial usage: an international patient-level cohort studyRefath Farzana, Stephan Jürgen Harbarth, Ly-Mee Yu, et al.
Expert Review of Anti-Infective Therapy|March 20, 2025
Current access, availability and use of antibiotics in primary care among key low- and middle-income countries and the policy implicationsZikria Saleem, Biset Asrade Mekonnen, Ebiowei Samuel Orubu, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 24, 2004
Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistanceMatthew T G Holden, Edward J Feil, Jodi A Lindsay, et al.
Pageof 11